
    
      This is a 2-arm, non-inferiority RCT. Patients undergoing total mesorectal excision for
      mid-low rectal cancer will be randomly assigned into two groups:

        -  pelvic drain

        -  no pelvic drain. Patients will be followed-up to assess the rates of anastomotic leaks,
           pelvic sepsis and secondary outcomes.
    
  